Transcription of 2017 ISMP Guidelines for Optimizing Safe Subcutaneous ...
{{id}} {{{paragraph}}}
2017 ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in AdultsTable of ContentsIntroduction 3 Risk Associated with Subcutaneous Insulin Use in Adults 5 Risk Associated with Prescribing Subcutaneous Insulin 6 Risk Associated with Dispensing Subcutaneous Insulin 6 Risk Associated with the Preparation and Administration of Subcutaneous Insulin 7 Risk Associated with the Use of Insulin Pens and Vials 9 Risk Associated with monitoring Patients on Subcutaneous Insulin 11 Risk Associated with Educating Patients on Subcutaneous Insulin 11 Developing Consensus Guidelines for Safe Subcutaneous Insulin Use 12 Safe Practice Guidelines for Subcutaneous Insulin Use in Adults 131.
drug therapy, knowledge deficits surrounding treatment, lack of automated clinical alert systems to track and trend glycemic control, and the amount of incremental nursing time needed for complex insulin management.11,12 Suboptimal ... monitoring and blood glucose goals.34,35
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}